Daré Bioscience, Inc. (DARE)
NASDAQ·Healthcare·Biotechnology
$2.08
-1.66%
Mkt Cap $14.57M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+478.3%
Consensus $12.00 vs current $2.08
NASDAQ·Healthcare·Biotechnology
$2.08
-1.66%
Mkt Cap $14.57M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+478.3%
Consensus $12.00 vs current $2.08